Autopsy report · NCT05541952

BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population

“New evidence points to a new candidate vaccine, with a superior trial to BCG.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Federal University of Mato Grosso

Sponsor type

University, hospital or other

Conditions

Latent Tuberculosis

Interventions

BCG

Participants

0

Sites

1

Countries

Brazil

Trials that died the same way

• Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
  “Trial not started due to accumulating evidence against HCQ for COVID” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.